Logo image of TRS

TRIMAS CORP (TRS) Stock Fundamental Analysis

NASDAQ:TRS - US8962152091 - Common Stock

38.46 USD
+0.46 (+1.21%)
Last: 9/3/2025, 3:44:08 PM
Fundamental Rating

5

Overall TRS gets a fundamental rating of 5 out of 10. We evaluated TRS against 22 industry peers in the Containers & Packaging industry. The financial health of TRS is average, but there are quite some concerns on its profitability. TRS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TRS had positive earnings in the past year.
In the past year TRS had a positive cash flow from operations.
Of the past 5 years TRS 4 years were profitable.
TRS had a positive operating cash flow in each of the past 5 years.
TRS Yearly Net Income VS EBIT VS OCF VS FCFTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

TRS's Return On Assets of 2.58% is in line compared to the rest of the industry. TRS outperforms 50.00% of its industry peers.
Looking at the Return On Equity, with a value of 5.22%, TRS is in line with its industry, outperforming 50.00% of the companies in the same industry.
TRS has a worse Return On Invested Capital (4.16%) than 68.18% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TRS is below the industry average of 7.26%.
Industry RankSector Rank
ROA 2.58%
ROE 5.22%
ROIC 4.16%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
TRS Yearly ROA, ROE, ROICTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

TRS has a Profit Margin of 3.83%. This is comparable to the rest of the industry: TRS outperforms 59.09% of its industry peers.
In the last couple of years the Profit Margin of TRS has declined.
The Operating Margin of TRS (6.69%) is worse than 63.64% of its industry peers.
TRS's Operating Margin has declined in the last couple of years.
TRS has a Gross Margin of 22.59%. This is in the better half of the industry: TRS outperforms 72.73% of its industry peers.
TRS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.69%
PM (TTM) 3.83%
GM 22.59%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
TRS Yearly Profit, Operating, Gross MarginsTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRS is destroying value.
TRS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TRS has less shares outstanding
The debt/assets ratio for TRS is higher compared to a year ago.
TRS Yearly Shares OutstandingTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TRS Yearly Total Debt VS Total AssetsTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.39 indicates that TRS is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.39, TRS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
TRS has a debt to FCF ratio of 13.43. This is a negative value and a sign of low solvency as TRS would need 13.43 years to pay back of all of its debts.
TRS has a Debt to FCF ratio (13.43) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.60 indicates that TRS is somewhat dependend on debt financing.
The Debt to Equity ratio of TRS (0.60) is better than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 13.43
Altman-Z 2.39
ROIC/WACC0.53
WACC7.82%
TRS Yearly LT Debt VS Equity VS FCFTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

TRS has a Current Ratio of 2.59. This indicates that TRS is financially healthy and has no problem in meeting its short term obligations.
TRS has a Current ratio of 2.59. This is amongst the best in the industry. TRS outperforms 95.45% of its industry peers.
A Quick Ratio of 1.44 indicates that TRS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.44, TRS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.44
TRS Yearly Current Assets VS Current LiabilitesTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

TRS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.92%, which is quite good.
Measured over the past years, TRS shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.59% on average per year.
TRS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.73%.
TRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.04% yearly.
EPS 1Y (TTM)10.92%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%41.86%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%14.25%

3.2 Future

TRS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.17% yearly.
Based on estimates for the next years, TRS will show a quite strong growth in Revenue. The Revenue will grow by 8.12% on average per year.
EPS Next Y24.03%
EPS Next 2Y20.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.14%
Revenue Next 2Y8.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRS Yearly Revenue VS EstimatesTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
TRS Yearly EPS VS EstimatesTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

TRS is valuated rather expensively with a Price/Earnings ratio of 19.93.
The rest of the industry has a similar Price/Earnings ratio as TRS.
When comparing the Price/Earnings ratio of TRS to the average of the S&P500 Index (26.90), we can say TRS is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.04 indicates a correct valuation of TRS.
Based on the Price/Forward Earnings ratio, TRS is valued a bit more expensive than 68.18% of the companies in the same industry.
TRS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.93
Fwd PE 16.04
TRS Price Earnings VS Forward Price EarningsTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.18% of the companies in the same industry are cheaper than TRS, based on the Enterprise Value to EBITDA ratio.
TRS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 49.28
EV/EBITDA 14.94
TRS Per share dataTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TRS's earnings are expected to grow with 20.17% in the coming years.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y20.17%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

TRS has a yearly dividend return of 0.41%, which is pretty low.
Compared to an average industry Dividend Yield of 3.16, TRS is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.32, TRS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.41%

5.2 History

TRS has been paying a dividend for over 5 years, so it has already some track record.
TRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
TRS Yearly Dividends per shareTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

17.66% of the earnings are spent on dividend by TRS. This is a low number and sustainable payout ratio.
DP17.66%
EPS Next 2Y20.17%
EPS Next 3YN/A
TRS Yearly Income VS Free CF VS DividendTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
TRS Dividend Payout.TRS Dividend Payout, showing the Payout Ratio.TRS Dividend Payout.PayoutRetained Earnings

TRIMAS CORP

NASDAQ:TRS (9/3/2025, 3:44:08 PM)

38.46

+0.46 (+1.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners103.13%
Inst Owner Change1.13%
Ins Owners5.87%
Ins Owner Change4.08%
Market Cap1.56B
Analysts76.67
Price Target40.22 (4.58%)
Short Float %9.03%
Short Ratio5.86
Dividend
Industry RankSector Rank
Dividend Yield 0.41%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP17.66%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-05 2025-08-05 (0.04)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.64%
Min EPS beat(2)13.72%
Max EPS beat(2)25.56%
EPS beat(4)2
Avg EPS beat(4)2.34%
Min EPS beat(4)-19.44%
Max EPS beat(4)25.56%
EPS beat(8)4
Avg EPS beat(8)-3.73%
EPS beat(12)5
Avg EPS beat(12)-4.83%
EPS beat(16)7
Avg EPS beat(16)-3.77%
Revenue beat(2)2
Avg Revenue beat(2)4.97%
Min Revenue beat(2)1.64%
Max Revenue beat(2)8.31%
Revenue beat(4)2
Avg Revenue beat(4)1.16%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)8.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.9%
Revenue beat(12)4
Avg Revenue beat(12)-3.33%
Revenue beat(16)4
Avg Revenue beat(16)-3.06%
PT rev (1m)15.47%
PT rev (3m)15.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.99%
EPS NY rev (1m)11.67%
EPS NY rev (3m)11.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.18%
Revenue NY rev (1m)4.37%
Revenue NY rev (3m)4.37%
Valuation
Industry RankSector Rank
PE 19.93
Fwd PE 16.04
P/S 1.61
P/FCF 49.28
P/OCF 17.65
P/B 2.19
P/tB 9.55
EV/EBITDA 14.94
EPS(TTM)1.93
EY5.02%
EPS(NY)2.4
Fwd EY6.23%
FCF(TTM)0.78
FCFY2.03%
OCF(TTM)2.18
OCFY5.67%
SpS23.96
BVpS17.6
TBVpS4.03
PEG (NY)0.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.58%
ROE 5.22%
ROCE 5.19%
ROIC 4.16%
ROICexc 4.26%
ROICexgc 7.75%
OM 6.69%
PM (TTM) 3.83%
GM 22.59%
FCFM 3.26%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
ROICexc(3y)4.82%
ROICexc(5y)5.17%
ROICexgc(3y)9.3%
ROICexgc(5y)10.22%
ROCE(3y)5.66%
ROCE(5y)5.96%
ROICexcg growth 3Y-26.13%
ROICexcg growth 5Y-19.63%
ROICexc growth 3Y-23.76%
ROICexc growth 5Y-16.4%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 13.43
Debt/EBITDA 3.28
Cap/Depr 87.86%
Cap/Sales 5.84%
Interest Coverage 3.38
Cash Conversion 68.19%
Profit Quality 85.02%
Current Ratio 2.59
Quick Ratio 1.44
Altman-Z 2.39
F-Score6
WACC7.82%
ROIC/WACC0.53
Cap/Depr(3y)86.35%
Cap/Depr(5y)84.94%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.46%
Profit Quality(3y)59.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.92%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%41.86%
EPS Next Y24.03%
EPS Next 2Y20.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.73%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%14.25%
Revenue Next Year10.14%
Revenue Next 2Y8.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.89%
EBIT growth 3Y-20.81%
EBIT growth 5Y-12.34%
EBIT Next Year53.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.84%
FCF growth 3Y-47.6%
FCF growth 5Y-22.52%
OCF growth 1Y24.54%
OCF growth 3Y-21.96%
OCF growth 5Y-3.34%